Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma

B. W. Loggie, R. A. Fleming, A. A. Hosseinian

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Urachal adenocarcinoma is an uncommon clinicopathologic entity associated with a dismal prognosis. We report a case of peritoneal carcinomatosis from urachal adenocarcinoma (signet cell type) treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). Prior to treatment, disease had progressed with systemic chemotherapy. The patient remained free of symptomatic peritoneal disease or local recurrence but eventually died 25 months after IPHC and 31 months after diagnosis due to widespread bone metastases.

Original languageEnglish (US)
Pages (from-to)446-448
Number of pages3
Issue number3
StatePublished - Sep 1997
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Urology


Dive into the research topics of 'Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma'. Together they form a unique fingerprint.

Cite this